Occurrence and predictors of adverse events associated with Linezolid in the treatment of patients with MDR-TB

被引：0

作者：

Oehadian, A. ^{[1
,2
]}

Bastos, M. L. ^{[3
,4
]}

Centis, R. ^{[5
]}

D'Ambrosio, L. ^{[6
]}

Migliorie, G. B. ^{[5
]}

Santoso, P. ^{[7
]}

Ruslami, R. ^{[8
]}

Menzies, D. ^{[9
,10
]}

机构：

[1] Univ Padjadjaran, Dr Hasan Sadikin Gen Hosp, Fac Med, Hematol & Oncol Med Div,Dept Internal Med, Bandung, Indonesia

[2] Univ Padjadjaran, Doctoral Study Program, Fac Med, Bandung, West Java, Indonesia

[3] McGill Univ, Res Inst, McGill Int TB Ctr, Montreal Ctr Hlth,Hlth Ctr, Montreal, PQ, Canada

[4] Univ Estado Rio De Janeiro, Social Med Inst, Rio De Janeiro, Brazil

[5] Ist Clin Sci Maugeri IRCCS, Serv Epidemiol Clin Malattie Resp, Tradate, Italy

[6] Publ Hlth Consulting Grp, Lugano, Switzerland

[7] Univ Padjadjaran, Dr Hasan Sadikin Gen Hosp, Dept Internal Med, Div Respirol & Crit Care,Fac Med, Bandung, Indonesia

[8] Padjadjaran State Univ, Dr Hasan Sadikin Gen Hosp, Dept Biomed Sci, Div Pharmacol, Bandung, Indonesia

[9] Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, 5252 Maisonneuve West,Room 3D-58, Montreal, PQ H4A 3S5, Canada

[10] McGill Int TB Ctr, 5252 Maisonneuve West,Room 3D-58, Montreal, PQ H4A 3S5, Canada

来源：

PULMONOLOGY | 2024年 / 30卷 / 02期

关键词：

MULTIDRUG-RESISTANT TUBERCULOSIS; TOLERABILITY;

D O I：

10.1016/j.pulmoe.2023.09.003

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：184 / 187

页数：4

共 7 条

[1] Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study
Bolhuis, Mathieu S.
Tiberi, Simon
Sotgiu, Giovanni
De Lorenzo, Saverio
Kosterink, Jos G. W.
van der Werf', Tjip S.
Miglioris, Giovanni Battista
Alffenaar, Jan-Willem C.
[J]. EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (04) : 1205 - 1207
[2] Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort
Koirala, S.
Borisov, S.
Danila, E.
Mariandyshev, A.
Shrestha, B.
Lukhele, N.
Dalcolmo, M.
Shakya, S. R.
Miliauskas, S.
Kuksa, L.
Manga, S.
Aleksa, A.
Denholm, J. T.
Khadka, H. B.
Skrahina, A.
Diktanas, S.
Ferrarese, M.
Bruchfeld, J.
Koleva, A.
Piubello, A.
Koirala, G. S.
Udwadia, Z. F.
Palmero, D. J.
Munoz-Torrico, M.
Gc, R.
Gualano, G.
Grecu, V., I
Motta, I
Papavasileiou, A.
Li, Y.
Hoefsloot, W.
Kunst, H.
Mazza-Stalder, J.
Payen, M-C
Akkerman, O. W.
Bernal, E.
Manfrin, V
Matteelli, A.
Hamdan, H. Mustafa
Marcos, M. Nieto
Cadinanos Loidi, J.
Cebrian Gallardo, J. J.
Duarte, R.
Escobar Salinas, N.
Gomez Rosso, R.
Laniado-Laborin, R.
Martinez Robles, E.
Quiros Fernandez, S.
Rendon, A.
Solovic, I
[J]. PULMONOLOGY, 2021, 27 (05): : 403 - 412
[3] Haematological adverse effects associated with linezolid in patients with drug-resistant tuberculosis: an exploratory study
Letswee, Gotlhe
Kamau, Hellen
Gaida, Razia
Truter, Ilse
[J]. INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2019, 27 (06) : 575 - 577
[4] A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis
Migliori, G. B.
Eker, B.
Richardson, M. D.
Sotgiu, G.
Zellweger, J. -P.
Skrahina, A.
Ortmann, J.
Girardi, E.
Hoffmann, H.
Besozzi, G.
Bevilacqua, N.
Kirsten, D.
Centis, R.
Lange, C.
[J]. EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (02) : 387 - 393
[5] Pratama Novan Yusuf Indra, 2021, Journal of Basic and Clinical Physiology and Pharmacology, V32, P777, DOI 10.1515/jbcpp-2020-0468
[6] Managing multidrug-resistant tuberculosis in children: review of recent developments
Schaaf, H. Simon
Garcia-Prats, Anthony J.
Hesseling, Anneke C.
Seddon, James A.
[J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2014, 27 (03) : 211 - 219
[7] Zhang P, 2022, China Infect Drug Resist, P2617

← 1 →